omalizumab 300 MG in 2 ML Auto-Injector

RxCUI: 2663920
RxNorm name: omalizumab 300 MG in 2 ML Auto-Injector
Display name: omalizumab 300 MG in 2 ML Auto-Injector
Full name: omalizumab 300 MG in 2 ML Auto-Injector
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
103976	Xolair	omalizumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
XOLAIR	OMALIZUMAB	Genentech, Inc.	7f6a2191-adfb-48b9-9bfa-0d9920479f0d	2025-12-02	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2663920

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
7f6a2191-adfb-48b9-9bfa-0d9920479f0d	omalizumab 300 MG in 2 ML Auto-Injector	PSN	31	These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR ® (omalizumab) injection, for subcutaneous use XOLAIR ® (omalizumab) for injection, for subcutaneous use Initial U.S. Approval: 2003	20251202
7f6a2191-adfb-48b9-9bfa-0d9920479f0d	omalizumab 300 MG per 2 ML Auto-Injector	SY	31	These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR ® (omalizumab) injection, for subcutaneous use XOLAIR ® (omalizumab) for injection, for subcutaneous use Initial U.S. Approval: 2003	20251202
7f6a2191-adfb-48b9-9bfa-0d9920479f0d	2 ML omalizumab 150 MG/ML Auto-Injector	SCD	31	These highlights do not include all the information needed to use XOLAIR safely and effectively. See full prescribing information for XOLAIR. XOLAIR ® (omalizumab) injection, for subcutaneous use XOLAIR ® (omalizumab) for injection, for subcutaneous use Initial U.S. Approval: 2003	20251202